RS Bio Labs · UK · Research Compound

GHK-Cu

DNA repair genes modulated Broad Institute Connectivity Map analysis · ≥50% expression change
One of the most extensively studied copper peptides in biochemical research

GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Cu²♠, CAS 49557-75-7) is a naturally occurring copper-binding tripeptide first isolated from human plasma in 1973. With over four decades of peer-reviewed publication it is among the most extensively characterised peptide compounds in biochemical literature — studied for extracellular matrix gene expression, fibroblast culture models, antioxidant enzyme pathways, and wound healing assays. RS Bio Labs supplies it at ≥99% HPLC-verified purity with a Certificate of Analysis on every order.

Buy GHK-Cu — £44.99 → Free UK shipping · COA included · 1–2 day dispatch

Supplied for in vitro research use only · Not for human or animal consumption · Not FDA / MHRA approved

47 DNA Repair Genes Modulated — Broad Institute Connectivity Map First Isolated from Human Plasma — 1973 ≥99% Purity · HPLC Verified Free UK Shipping · COA Every Order CAS 49557-75-7 · Glycyl-L-Histidyl-L-Lysine-Cu²+ ECM Gene Expression · Fibroblast Research · Wound Models Research Use Only · Not For Human Consumption 47 DNA Repair Genes Modulated — Broad Institute Connectivity Map First Isolated from Human Plasma — 1973 ≥99% Purity · HPLC Verified Free UK Shipping · COA Every Order CAS 49557-75-7 · Glycyl-L-Histidyl-L-Lysine-Cu²+ ECM Gene Expression · Fibroblast Research · Wound Models Research Use Only · Not For Human Consumption

Payments are processed by Stripe, via CodeCoded Ltd. Once settled, an email will be sent by our team to confirm shipping details. We do not store personal or card details for your privacy and security.

⚠ Research Use Only — Important GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper complex, CAS 49557-75-7) is supplied by RS Bio Labs solely as a lyophilised laboratory research reagent for in vitro scientific use. It is NOT approved by the MHRA, FDA, or any regulatory authority for human use, self-administration, or therapeutic application of any kind. Injectable forms were added to the FDA Category 2 compounding list in 2023. Not for human or animal consumption. By purchasing you confirm you are a qualified researcher and agree to our Terms & Conditions.